triple glp-1/gip/glucagon receptor agonist LY3437943, a novel glucagon, GIP, and GLP-1 for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide vs Tirzepatide ๐ฌ What's
Description
Nausea, vomiting, and diarrhea are among the most common adverse effects of GLP-1 receptor agonists, with frequencies varying by product and dose
This is important, notes Alkhaddo, because sleep apnea is far more than snoring
GLP-1 medicines induce substantial metabolic improvements in the liver, with reduction in liver weight and lipid accumulation largely attributed to weight loss
Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery
Metabolism (2016) 65(8):118395
